Immune Dysregulation in Down Syndrome: Implications for Infectious Susceptibility and Vaccine Response
Journal of Clinical Immunology · Published 2026-07-24 · DOI 10.1007/s10875-026-02054-6
Free full text
Authors (5)
Sofía Solari-Hernández, Enrique González-Madrid, Pablo A. González, Susan M. Bueno, Alexis M. Kalergis
Abstract
PubPorta does not have an abstract for this article yet.
Read the article at the publisher →
Publication details
- Year
- 2026
Citation
Solari-Hernández, S., González-Madrid, E., González, P., et al. (2026). Immune Dysregulation in Down Syndrome: Implications for Infectious Susceptibility and Vaccine Response. Journal of Clinical Immunology. https://doi.org/10.1007/s10875-026-02054-6
Related articles
- Acute Leukemia in Children with Down Syndrome: A Report from the Hellenic HESPHO Group · Hemato · 2025 · Cites or is cited by this article
- Immunologic profiles and infection patterns in patients with down syndrome: A retrospective review · Clinical Immunology Communications · 2025 · Cites or is cited by this article
- Genetic Diagnosis and Identification of a Novel De Novo RELA Variant in Familial Behçet-like Autoinflammatory Syndrome Type 3: A Case Report · Journal of Clinical Immunology · 2026 · Same journal
- Biallelic MCM10 Deficiency Presenting with Natural Killer Cell Deficiency, Poikiloderma and EBV-Associated Malignancy · Journal of Clinical Immunology · 2026 · Same journal
- Hypoproteinemia and Hypogammaglobulinemia Due to a Homozygous FCGRT Mutation · Journal of Clinical Immunology · 2026 · Same journal
- Disseminated Tuberculosis and Early-Onset SLE in a Child with a Novel STAT1 Gain-of-Function Mutation: a Case Report · Journal of Clinical Immunology · 2026 · Same journal
- Humoral Immune Abnormalities in Transient Childhood Neutropenia: Insights From a 10-year Cohort Study in a Tertiary Center · Journal of Clinical Immunology · 2026 · Same journal
- Phenotypic Heterogeneity in CD40 Ligand Deficiency: Long-term Follow-up of a Patient with the c.156G > A Splice Variant · Journal of Clinical Immunology · 2026 · Same journal
- First-in-Human, Phase 1, Randomized, Double-Blind, Placebo-Controlled Study of TNX-1500, an Fc-Modified anti-CD154 Monoclonal Antibody, Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single-Ascending Doses in Healthy Adults · Journal of Clinical Immunology · 2026 · Same journal
- Antigen Microarray Reveals Broad and Subclinical Autoimmunity in Patients with Inborn Errors of Immunity · Journal of Clinical Immunology · 2026 · Same journal